Deepverge Equipment Selected for UK Covid-19 Infrastructure Trial
October 28 2021 - 6:28AM
Dow Jones News
By Ian Walker
Deepverge PLC said Thursday that its enhanced monitoring
equipment is to be installed as part of the U.K. Government's
national Covid-19 infrastructure trial.
The environmental and life-sciences company said the equipment
is worth 480,000 pounds ($659,520) and it expects to get revenue
from installations next fiscal year, provided the trial is
successful.
The trial is expected to last until the end of February
2022.
The multiple-unit installation consists of six upgraded Microtox
toxicity monitoring and new models of the Microtox PD range for
SARS-CoV-2 and other pathogen monitoring, Deepverge said.
"Deepverge is well-placed to capitalize on current and future
opportunities to work with governments, industries bodies and
private companies to create a co-ordinated solution, not only to
the current global pandemic but also future health challenges,"
Chief Executive Gerry Brandon said.
Shares at 0952 GMT were up 2.25 pence, or 8.5%, at 28.75
pence.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
October 28, 2021 06:13 ET (10:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Integumen (LSE:SKIN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Integumen (LSE:SKIN)
Historical Stock Chart
From Apr 2023 to Apr 2024